
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Ageless Tastefulness: An Outline of Valuable Gemstones and Adornments - 2
Simple Consideration Plants for Home and Office: An Aide - 3
Living Abroad: Social Inundation and Self-improvement - 4
How to watch Dick Clark’s New Year’s Rockin’ Eve with Ryan Seacrest: Start time, TV channel, performers and more - 5
Rocket Lab launches mystery satellite for 'confidential commercial customer' (video)
Agios Pharma shares jump as US FDA expands approval for its blood disorder drug
The Most Compelling Books of the 10 years
Scientists find new clues to why female fertility declines with age
Step by step instructions to Explore the Close to home Consequence of Cellular breakdown in the lungs
'Senseless violence' erupts at Christmas tree lighting; 4 injured
Vote In favor of Your #1 Compelling Female Producer
Rights groups condemn Israel Police decision to ban Sudan Genocide protests nationwide
An Ideal Getaway - Spots for Solo Travel
Step by step instructions to Lessen Your Gamble of Creating Cellular breakdown in the lungs













